These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17234711)

  • 21. In Vitro and in Vivo Characterization of MOD-4023, a Long-Acting Carboxy-Terminal Peptide (CTP)-Modified Human Growth Hormone.
    Hershkovitz O; Bar-Ilan A; Guy R; Felikman Y; Moschcovich L; Hwa V; Rosenfeld RG; Fima E; Hart G
    Mol Pharm; 2016 Feb; 13(2):631-9. PubMed ID: 26713839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-acting growth hormones produced by conjugation with polyethylene glycol.
    Clark R; Olson K; Fuh G; Marian M; Mortensen D; Teshima G; Chang S; Chu H; Mukku V; Canova-Davis E; Somers T; Cronin M; Winkler M; Wells JA
    J Biol Chem; 1996 Sep; 271(36):21969-77. PubMed ID: 8703002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-acting interferon-alpha 2a modified with a trimer-structured polyethylene glycol: preparation, in vitro bioactivity, in vivo stability and pharmacokinetics.
    Jo YW; Youn YS; Lee SH; Kim BM; Kang SH; Yoo M; Choi EC; Lee KC
    Int J Pharm; 2006 Feb; 309(1-2):87-93. PubMed ID: 16406701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced circulation half-life of site-specific PEGylated rhG-CSF: optimization of PEG molecular weight.
    Zhai Y; Zhao Y; Lei J; Su Z; Ma G
    J Biotechnol; 2009 Jul; 142(3-4):259-66. PubMed ID: 19497340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of unilateral arterial infusion of GH and IGF-I on tibial longitudinal bone growth in hypophysectomized rats.
    Nilsson A; Isgaard J; Lindahl A; Peterson L; Isaksson O
    Calcif Tissue Int; 1987 Feb; 40(2):91-6. PubMed ID: 3105839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant human growth hormone (GH)-binding protein enhances the growth-promoting activity of human GH in the rat.
    Clark RG; Mortensen DL; Carlsson LM; Spencer SA; McKay P; Mulkerrin M; Moore J; Cunningham BC
    Endocrinology; 1996 Oct; 137(10):4308-15. PubMed ID: 8828490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic/pharmacodynamic (PK/PD) differentiation of native and PEGylated recombinant human growth hormone (rhGH and PEG-rhGH) in the rat model of osteoarthritis.
    Nemirovskiy O; Zheng YJ; Tung D; Korniski B; Settle S; Skepner A; Yates M; Aggarwal P; Sunyer T; Aguiar DJ
    Xenobiotica; 2010 Aug; 40(8):586-92. PubMed ID: 20509748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of growth hormone and alpha calcidol on trabecular and cortical bones in hypophysectomized rats.
    Chaudhry AA; Castro-Magana M; Aloia JF; Yeh JK
    Pediatr Res; 2009 Apr; 65(4):403-8. PubMed ID: 19092717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical and enzymatic site specific PEGylation of hGH.
    da Silva Freitas D; Mero A; Pasut G
    Bioconjug Chem; 2013 Mar; 24(3):456-63. PubMed ID: 23432141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Site-specific PEGylation enhances the pharmacokinetic properties and antitumor activity of interferon beta-1b.
    Lee JI; Eisenberg SP; Rosendahl MS; Chlipala EA; Brown JD; Doherty DH; Cox GN
    J Interferon Cytokine Res; 2013 Dec; 33(12):769-77. PubMed ID: 23962003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children.
    Hou L; Chen ZH; Liu D; Cheng YG; Luo XP
    Drug Des Devel Ther; 2016; 10():13-21. PubMed ID: 26719670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Site-specific PEGylation for high-yield preparation of Lys(21)-amine PEGylated growth hormone-releasing factor (GRF) (1-29) using a GRF(1-29) derivative FMOC-protected at Tyr(1) and Lys(12).
    Youn YS; Lee KC
    Bioconjug Chem; 2007; 18(2):500-6. PubMed ID: 17243755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats.
    Cox GN; McDermott MJ; Merkel E; Stroh CA; Ko SC; Squires CH; Gleason TM; Russell D
    Endocrinology; 1994 Nov; 135(5):1913-20. PubMed ID: 7525258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intermittent parathyroid hormone treatment increases osteoblast number, steady state messenger ribonucleic acid levels for osteocalcin, and bone formation in tibial metaphysis of hypophysectomized female rats.
    Schmidt IU; Dobnig H; Turner RT
    Endocrinology; 1995 Nov; 136(11):5127-34. PubMed ID: 7588250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PEGylation improves the pharmacokinetic properties and ability of interferon gamma to inhibit growth of a human tumor xenograft in athymic mice.
    Fam CM; Eisenberg SP; Carlson SJ; Chlipala EA; Cox GN; Rosendahl MS
    J Interferon Cytokine Res; 2014 Oct; 34(10):759-68. PubMed ID: 24841172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of frequency of growth hormone administration on longitudinal bone growth and body weight in hypophysectomized rats.
    Jansson JO; Albertsson-Wikland K; Edén S; Thorngren KG; Isaksson O
    Acta Physiol Scand; 1982 Feb; 114(2):261-5. PubMed ID: 7136757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isoform separation and structural identification of mono-PEGylated recombinant human growth hormone (PEG-rhGH) with pH gradient chromatography.
    Qin X; Li J; Li Y; Gan Y; Huang H; Liang C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():206-213. PubMed ID: 28153672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic Code Expansion Enables Site-Specific PEGylation of a Human Growth Hormone Receptor Antagonist through Click Chemistry.
    Tamshen K; Wang Y; Jamieson SMF; Perry JK; Maynard HD
    Bioconjug Chem; 2020 Sep; 31(9):2179-2190. PubMed ID: 32786367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pegylated peptides. IV. Enhanced biological activity of site-directed pegylated GRF analogs.
    Felix AM; Lu YA; Campbell RM
    Int J Pept Protein Res; 1995; 46(3-4):253-64. PubMed ID: 8537179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-acting forms of Sonic hedgehog with improved pharmacokinetic and pharmacodynamic properties are efficacious in a nerve injury model.
    Pepinsky RB; Shapiro RI; Wang S; Chakraborty A; Gill A; Lepage DJ; Wen D; Rayhorn P; Horan GS; Taylor FR; Garber EA; Galdes A; Engber TM
    J Pharm Sci; 2002 Feb; 91(2):371-87. PubMed ID: 11835197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.